Grant of Options
07/11/2024 07:00
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241107:nRSG3379La&default-theme=true
RNS Number : 3379L SulNOx Group PLC 07 November 2024
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION
11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310
7 November 2024
SulNOx Group Plc
(the "Company" or "SulNOx")
Granting of Share Options
(Aquis Stock Exchange: SNOX)
The board of directors of the Company (the "Board") announces that it
yesterday granted share options to a consultant. These options are granted
under an unapproved share option scheme. 500,000 options (the "Options")
have been granted for ordinary shares of 2 pence each in the capital of the
Company ("Ordinary Shares") with a 10-year life.
The Options have been granted with an exercise price of 52.0p, a premium to
the average closing price at which the Ordinary Shares traded for the last
five days of 46.2 pence. These Options vest on 31 October 2025 (with a pro
rata adjustment should the consultant cease to be contracted to the Company
prior to that date).
- Ends -
For further information please contact:
SulNOx Group plc Tel: 07624 491 821
Steven Cowin, CFO
Allenby Capital Limited Tel: 020 3328 5656
(AQSE Corporate Adviser)
Nick Harriss / John Depasquale
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NEXQKOBPABDKPDK